“…It has been reported that IL‐38 may play an anti‐inflammatory role in arthritis (Boutet et al, 2017), psoriasis (Han et al, 2019; Mercurio et al, 2018), systemic lupus erythematosus (Chu et al, 2017; Rudloff et al, 2015), inflammatory bowel disease (Xie et al, 2020), sepsis (Ge, Huang, Wu, Dong, & Yao, 2020; F. Xu et al, 2018), diabetes (Liu, Chen, Zhou, Mu, & Liu, 2020), myocardial injury (Wei et al, 2020), and asthma (Matsuoka et al, 2019; Sun et al, 2020). Recently, we also found that IL‐38 has the effect of inhibiting obesity‐induced inflammation (K. Xu et al, 2019) and liver inflammatory damage (Yuan et al, 2016).…”